PS 873266
Alternative Names: PS873266Latest Information Update: 03 Dec 2019
At a glance
- Originator Celgene Corporation; Pharmacopeia Drug Discovery
- Developer Celgene Corporation
- Class Small molecules
- Mechanism of Action Phosphotransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 20 Nov 2019 Celgene Corporation has been acquired by Bristol-Myers Squibb
- 04 Nov 2017 No recent reports of development identified for phase-I development in Inflammation in USA
- 11 Apr 2011 Phase-I development is ongoing in USA